AAAAAA

   
Results: 1-19 |
Results: 19

Authors: YAN JM LU ZH WALSH GM WHEELER RH DIASIO RB
Citation: Jm. Yan et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF 9-(3-PYRIDYLMETHYL)-9-DEAZAGUANINE (BCX-34) IN BIOLOGICAL-FLUIDS, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 295-303

Authors: LIU TP MEREDITH RF SALEH MN WHEELER RH KHAZAELI MB PLOTT WE SCHLOM J LOBUGLIO AF
Citation: Tp. Liu et al., CORRELATION OF TOXICITY WITH TREATMENT PARAMETERS FOR I-131 CC49 RADIOIMMUNOTHERAPY IN 3 PHASE-II CLINICAL-TRIALS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(2), 1997, pp. 79-87

Authors: ROBERT F SOONG SJ WHEELER RH
Citation: F. Robert et al., A PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH RECURRENT HEAD AND NECK-CANCER - IDENTIFICATION OF AN ACTIVE NEW AGENT, American journal of clinical oncology, 20(3), 1997, pp. 298-302

Authors: MEREDITH RF KHAZAELI MB PLOTT WE GRIZZLE WE LIU TP SCHLOM J RUSSELL CD WHEELER RH LOBUGLIO AF
Citation: Rf. Meredith et al., PHASE-II STUDY OF DUAL I-131-LABELED MONOCLONAL-ANTIBODY THERAPY WITHINTERFERON IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Clinical cancer research, 2(11), 1996, pp. 1811-1818

Authors: ROBERT F CHEN S MILLER AA LEE BC MOLTHROP DC WHEELER RH
Citation: F. Robert et al., PHASE-I AND PHARMACOLOGICAL STUDY OF 7-DAY AND 21-DAY CONTINUOUS ETOPOSIDE INFUSION IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 459-465

Authors: ROBERT F MOLTHROP DC MILLER AA LEE BC CHEN S WHEELER RH
Citation: F. Robert et al., PROLONGED INFUSION OF ETOPOSIDE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, American journal of clinical oncology, 19(5), 1996, pp. 483-486

Authors: MEREDITH RF PARTRIDGE EE ALVAREZ RD KHAZAELI MB PLOTT G RUSSELL CD WHEELER RH LIU TP GRIZZLE WE SCHLOM J LOBUGLIO AF
Citation: Rf. Meredith et al., INTRAPERITONEAL RADIOIMMUNOTHERAPY OF OVARIAN-CANCER WITH LUTETIUM-177-CC49, The Journal of nuclear medicine, 37(9), 1996, pp. 1491-1496

Authors: SALEH MN DIASIO RB SAMS WM WHEELER RH GREGG X OMURA GA WALSH GM
Citation: Mn. Saleh et al., PHASE-I EVALUATION OF ORAL BCX-34 (PELDESINE) IN CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 88(10), 1996, pp. 2277-2277

Authors: MEREDITH RF KHAZAELI MB PLOTT WE SPENCER SA WHEELER RH BRADY LW WOO DV LOBUGLIO AF
Citation: Rf. Meredith et al., INITIAL CLINICAL-EVALUATION OF IODINE-125-LABELED CHIMERIC 17-1A FOR METASTATIC COLON-CANCER, The Journal of nuclear medicine, 36(12), 1995, pp. 2229-2233

Authors: SALEH MN KHAZAELI MB WHEELER RH BUCY RP LIU TP EVERSON MP MUNN DH SCHLOM J LOBUGLIO AF
Citation: Mn. Saleh et al., PHASE-II TRIAL OF MURINE MONOCLONAL-ANTIBODY D612 COMBINED WITH RECOMBINANT HUMAN MONOCYTE COLONY-STIMULATING FACTOR (RHM-CSF) IN PATIENTS WITH METASTATIC GASTROINTESTINAL CANCER, Cancer research, 55(19), 1995, pp. 4339-4346

Authors: WHEELER RH HERNDON JE CLAMON GH GREEN MR
Citation: Rh. Wheeler et al., PHASE-II STUDY OF RECOMBINANT INTERFERON-BETA AT MAXIMUM TOLERATED DOSE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of immunotherapy with emphasis on tumor immunology, 15(3), 1994, pp. 212-216

Authors: ROBERT F WHEELER RH MOLTHROP D BAILEY A CHEN SD
Citation: F. Robert et al., PHASE-2 STUDY OF PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN COMBINATION WITH WEEKLY CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER, American journal of clinical oncology, 17(5), 1994, pp. 383-386

Authors: CHEN SD SOONG SJ WHEELER RH
Citation: Sd. Chen et al., AN EFFICIENT MULTIPLE-STAGE PROCEDURE FOR PHASE-II CLINICAL-TRIALS THAT HAVE HIGH RESPONSE RATE OBJECTIVES, Controlled clinical trials, 15(4), 1994, pp. 277-283

Authors: MOLTHROP DC WHEELER RH HALL KM PRCHAL JT
Citation: Dc. Molthrop et al., EVALUATION OF THE METHEMOGLOBINEMIA ASSOCIATED WITH SULOFENUR, Investigational new drugs, 12(2), 1994, pp. 99-102

Authors: MEREDITH RF BUESCHEN AJ KHAZAELI MB PLOTT WE GRIZZLE WE WHEELER RH SCHLOM J RUSSELL CD LIU TP LOBUGLIO AF
Citation: Rf. Meredith et al., TREATMENT OF METASTATIC PROSTATE CARCINOMA WITH RADIOLABELED ANTIBODYCC49, The Journal of nuclear medicine, 35(6), 1994, pp. 1017-1022

Authors: MYERS RB MEREDITH RF SCHLOM J LOBUGLIO AF BUESCHEN AJ WHEELER RH STOCKARD CR GRIZZLE WE
Citation: Rb. Myers et al., TUMOR-ASSOCIATED GLYCOPROTEIN-72 IS HIGHLY EXPRESSED IN PROSTATIC ADENOCARCINOMAS, The Journal of urology, 152(1), 1994, pp. 243-246

Authors: MEREDITH RF KHAZAELI MB PLOTT WE LIU T RUSSELL CD WHEELER RH LOBUGLIO AF
Citation: Rf. Meredith et al., EFFECT OF HUMAN IMMUNE-RESPONSE ON REPEAT COURSES OF I-131 CHIMERIC B72.3 ANTIBODY THERAPY, Antibody immunoconjugates, and radiopharmaceuticals, 6(1), 1993, pp. 39-46

Authors: SALEH MN KHAZAELI MB GRIZZLE WE WHEELER RH LAWSON S LIU TP RUSSELL C MEREDITH R SCHLOM J LOBUGLIO AF
Citation: Mn. Saleh et al., A PHASE-I CLINICAL-TRIAL OF MURINE MONOCLONAL-ANTIBODY D612 IN PATIENTS WITH METASTATIC GASTROINTESTINAL CANCER, Cancer research, 53(19), 1993, pp. 4555-4562

Authors: WHEELER RH HINSON C
Citation: Rh. Wheeler et C. Hinson, REDUCTIONS IN METROPOLITAN WORKPLACE SIZE - REGIONAL VARIATIONS, Sociology and social research, 76(4), 1992, pp. 197-199
Risultati: 1-19 |